EIKN Eikon Therapeutics, Inc.

NEUTRAL Impact: 2/10 8-K
Horizon immediate Filed Jun 10, 2026 Processed 2d 13h ago SEC 0001193125-26-265861
8-K context-dependent: Items 5.02

Price Chart

Loading chart...

Executive Summary

Eikon Therapeutics appointed Ma. Fatima D. Francisco as a Class I director effective June 15, 2026, with standard non-employee director compensation including a $50,000 annual retainer and an option to purchase 85,937 shares at $8.96 per share. This is a routine board appointment with no material financial impact.

Actionable Insight

Routine board appointment with no immediate trading implications. Monitor for any future director transactions or changes in board composition.

Key Facts

  • Ma. Fatima D. Francisco appointed to the Board as Class I director, effective June 15, 2026.
  • She will serve on the Compensation Committee.
  • Annual retainer of $50,000 paid quarterly, prorated for partial service.
  • Initial option grant of 85,937 shares at $8.96 per share, vesting monthly over 48 months.
  • Standard indemnification agreement entered into.

Financial Impact

Standard director compensation: annual retainer of $50,000 and option grant valued at approximately $770,000 using Black-Scholes (based on 85,937 shares at $8.96 exercise price, but actual value not disclosed).

dilutionoption compensation expense

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (12 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-265861
Document: 0001193125-26-265861-index-headers.html0001193125-26-265861
Document: 0001193125-26-265861-index.html0001193125-26-265861
Document: 0001193125-26-265861.txt0001193125-26-265861
3 reports for EIKN
Performance horizon
Filters
Rows
Reports for EIKN — sortable, filterable
Type Now
Jun 10, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$8.35 awaiting T+5awaiting T+5$8.75 (+4.79%)
Jun 1, 2026
11d ago
8-K
NEUTRAL ★ 5/10
$10.79 $8.96▼ −16.96%▼ −14.21%$8.75 (−18.91%)
May 30, 2026
13d ago
Press Release
NEUTRAL ★ 5/10
$10.79 $8.96▼ −16.96%▼ −14.21%$8.75 (−18.91%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (52h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access